1-7 of 7
Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD4 + T Cell Fate in Multiple Myeloma

Rachel Elizabeth Cooke, BSc, FRACP, FRCPA, MBBS, Jessica Chung, PhD, Sarah Gabriel, PhD, Hang Quach, MD FRACP, FRCPA, MBBS, Simon J. Harrison, MBBS, MRCP, FRCPath, FRACP, PhD, H. Miles Prince, MD FRACP, FRCPA, Rachel Koldej, PhD, David Ritchie, MBChB, PhD FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 4494.
https://doi.org/10.1182/blood-2018-99-117674
Published: 2018
Journal Articles

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Elderly Multiple Myeloma (MM) Patients Aged ≥ 65 Years: A Multi-Centre Australian Experience

Jeremy An Ke Er, MBBS, David Routledge, MBChB, BSc, MSc, MRCP UK, FRCPath UK, RACP, Jennifer Hempton, RN,GCNSc(Apheresis), Colin Wood, Trish Joyce, Simon J. Harrison, MBBS, MRCP, FRCPath, FRACP, PhD, Philip Campbell, MBBS, FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 3441.
https://doi.org/10.1182/blood-2018-99-114049
Published: 2018
Journal Articles

Novel Combination Therapy Targeting rDNA Transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM

Kylee H Maclachlan, BSc, MBChB, FRACP, FRCPA, Andrew Cuddihy, PhD, Nadine Hein, PhD, Carleen Cullinane, PhD, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, Ross Hannan, PhD, Gretchen Poortinga, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1945.
https://doi.org/10.1182/blood-2018-99-113765
Published: 2018
Journal Articles

Carfilzomib Thalidomide and Dexamethasone Is Safe and Effective in the Treatment of Relapsed/Refractory Multiple Myeloma: Preliminary Outcome from the Open Label Phase II ALLGMM018/AMN003 Study

Hang Quach, MDFRACP,FRCPA,MBBS, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Jane Estell, MBBS FRACP, Noemi Horvath, MBBS FRACP FRCPA, Nick Murphy, MBBS FRACP FRCPA, Richard Eek, MBCHB, Bradley Augustson, MBBS FRACP FRCPA, Philip Campbell, MBBS, FRACP, FRCPA, Rajeev Rajagopal, Akash Kalro, MD, Robyn Hemme, Belinda Butcher, BSc(Hons) MBiostat PhDCMPP AStat, Tracey Gerber, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Brian GM Durie, MD, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1955.
https://doi.org/10.1182/blood-2018-99-111434
Published: 2018
Journal Articles

RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study

Amit Khot, MBBS, MD MRCP, FRCPath, FRACP, Natalie Brajanovski, BSc, Donald P Cameron, BSc, Gretchen Poortinga, PhD, Elaine Sanij, PhD, John Lim, PharmD, John Soong, MD FCAP, Nadine Hein, PhD, Emma Link, DPhil, Richard B Pearson, PhD, Ross Hannan, Grant A. McArthur, MBBS, PhD BSc, FRACP, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3835.
https://doi.org/10.1182/blood.V130.Suppl_1.3835.3835
Published: 2017
Journal Articles

Determinants of Long-Term Survival Following Allogeneic Stem Cell Transplantation for Multiple Myeloma: A Multi-Centre Analysis Across the United Kingdom and Australia

Salvatore Fiorenza, MBBS PhDMPH BSc, David J M Routledge, MSc, PGCert, MRCP, FRCPath, Jenny Collins, BSc, Michael J Shipton, MBChB, BSc, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, James Cavet, Eleni Tholouli, MD PhD, David Ritchie, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4569.
https://doi.org/10.1182/blood.V130.Suppl_1.4569.4569
Published: 2017
Journal Articles

Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma

Kylee H Maclachlan, FRACP,FRCPA, Andrew Cuddihy, PhD, Nadine Hein, PhD, Carleen Cullinane, PhD, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, Ross Hannan, PhD, Gretchen Poortinga, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1805.
https://doi.org/10.1182/blood.V130.Suppl_1.1805.1805
Published: 2017